Results 231 to 240 of about 466,155 (352)

Partial Purification and Characterization of Angiotensin-Converting Enzyme in Mouse and Human Skin

, 1982
Akira Hara, Kimie Fukuyama, William L. Epstein   +2 more
openalex   +1 more source

The opposing effects of chronic angiotensin-converting enzyme blockade by captopril on the responses to exogenous angiotensin II and vasopressin vs. norepinephrine in rats. [PDF]

, 1981
F Spertini, H R Brunner, Bernard Waeber, Haralambos Gavras   +3 more
openalex   +1 more source

Angiotensin Converting Enzyme 2: A Double-Edged Sword.

Circulation, 2020
Kaiming Wang, Mahmoud Gheblawi, G. Oudit
semanticscholar   +1 more source

Role of Bradykinin in Anaphylactoid Reactions during Hemodialysis with AN69 Dialyzers [PDF]

, 1993
Barkhausen, Regina, Fink, Edwin, Heidland, August, Kulzer, Peter, Schaefer, Liliana, Schaefer, Roland M.   +5 more
core   +1 more source

Association of angiotensin-converting enzyme 2 gene polymorphisms with hypertension and treatment response to hydroxychloroquine in Iranian people with coronavirus disease 2019: A cross-sectional study. [PDF]

J Int Med Res
Jafary F, Kazemi M, Zarean M, Khoshhali M, Karimian M, Fani F, Shahzamani K.   +6 more
europepmc   +1 more source

Increased or decreased thirst caused by inhibition of angiotensin‐converting enzyme in the rat.

, 1984
Mark D. Evered, Marilyn M. Robinson
openalex   +2 more sources

Angiotensin-converting enzyme in cultured endothelial cells. Synthesis, degradation, and transfer to culture medium. [PDF]

, 1983
Shanfun Ching, Lyle W. Hayes, Linda L. Slakey   +2 more
openalex   +1 more source

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

, 2000
S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais   +5 more
semanticscholar   +1 more source

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019

Mayo Clinic proceedings, 2020
F. Sanchis-Gomar, C. Lavie, C. Pérez-Quilis, B. Henry, G. Lippi   +4 more
semanticscholar   +1 more source

A Letter to the Editor on "Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients with Hypertension Combined Prediabetes". [PDF]

J Clin Hypertens (Greenwich)
Khan G.
europepmc   +1 more source